Osteocalcin effect on human β-cells mass and function

Endocrinology (United States)

Volumn 156, Issue 9, 2015, Pages 3137-3146

  Sabek, Omaima M ^a,b   Nishimoto, Satoru Ken ^c   Fraga, Daniel ^a   Tejpal, Neelam ^a   Ricordi, Camillo ^d   Gaber, A O ^a,b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; HUMAN INSULIN; INSULIN; OSTEOCALCIN; SULFONYLUREA RECEPTOR;

ADULT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GLUCOSE HOMEOSTASIS; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; INSULIN SENSITIVITY; LASER SCANNING CYTOMETRY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; BOVINE; CELL CULTURE; DRUG EFFECTS; MIDDLE AGED; NONOBESE DIABETIC MOUSE; PANCREAS ISLET TRANSPLANTATION; SCID MOUSE; SECRETION (PROCESS);

ADULT; ANIMALS; C-PEPTIDE; CATTLE; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE, INBRED NOD; MICE, SCID; MIDDLE AGED; OSTEOCALCIN;

EID: 84942801795     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/EN.2015-1143     Document Type: Article

References (54)

1. Kadri N, Korpos E, Gupta S., et al. CD4(+) type IINKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetes. J Immunol. 2012; 188(7):3138-3149.
2. Del Prato S. Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies. Diabet Med. 2009; 26(12):1185-1192.
3. Lebowitz MR, Blumenthal SA The molar ratio of insulin to C-peptide. An aid to the diagnosis of hypoglycemia due to surreptitious (or inadvertent) insulin administration. Arch Intern Med. 1993; 153(5): 650-655.
4. Palmer JP, Fleming GA, Greenbaum C.J., et al. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes. 2004; 53(1):250-264.
5. The DCCT Research Group. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual β-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). J Clin Endocrinol Metab. 1987; 65(1): 30-36.
6. Rewers MN J., Kretowski A. Type 1 diabetes: cellular, molecular, clinical immunology. In: Eisenbarth GG, ed. Epidemiology of Type I Diabetes. Aurora, CO: Barbara Davis Center for Diabetes; 2010.
7. Wajchenberg BL. β-Cell failure in diabetes and preservation by clinical treatment. Endocr Rev. 2007; 28(2):187-218.
8. Noguchi H. Stem cells for the treatment of diabetes. Endocr J. 2007; 54(1):7-16.
9. Baggio LL, Drucker DJ Therapeutic approaches to preserve islet mass in type 2 diabetes. Annu Rev Med. 2006; 57:265-281.
10. Vilsboll T. The effects of glucagon-like peptide-1 on the β cell. Diabetes Obes Metab. 2009; 11(Suppl 3):11-18.
11. Lovshin JA, Drucker DJ Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol. 2009; 5(5):262-269.
12. White MG, Marshall HL, Rigby R, et al Expression of mesenchymal and α-cell phenotypic markers in islet β-cells in recently diagnosed diabetes. Diabetes Care. 2013; 36(11):3818-3820.
13. Alonso LC, Yokoe T, Zhang P., et al. Glucose infusion in mice: a new model to induce β-cell replication. Diabetes. 2007; 56(7):1792-1801.
14. Dor Y, Brown J, Martinez O.I., Melton DA. Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 2004; 429(6987):41-46.
15. Nir T, Melton DA, Dor Y. Recovery from diabetes in mice by β cell regeneration. J Clin Invest. 2007; 117(9):2553-2561.
16. Sorenson RL, Brelje TC Adaptation of islets of Langerhans to pregnancy: β-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res. 1997; 29(6):301-307.
17. Zhang YQ, Sarvetnick N. Development of cell markers for the identification and expansion of islet progenitor cells. Diabetes Metab Res Rev. 2003; 19(5):363-374.
18. Ducy P, Amling M, Takeda S., et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 2000; 100(2):197-207.
19. Lee NK, Sowa H, Hinoi E., et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007; 130(3):456-469.
20. Ferron M, Hinoi E, Karsenty G., Ducy P. Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA. 2008; 105(13):5266-5270.
21. Kanazawa I, Yamaguchi T, Yamamoto M., et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009; 94(1):45-49.
22. Pittas AG, Harris SS, Eliades M, Stark P., Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab. 2009; 94(3):827-832.
23. Aittoniemi J, Fotinou C, Craig T.J., de Wet H, Proks P, Ashcroft FM Review. SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator. Philos Trans R Soc Lond B Biol Sci. 2009; 364(1514):257-267.
24. Fernández-Real J.M., Izquierdo M, Ortega F., et al. The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab. 2009; 94(1):237-245.
25. Nishimoto SK, Price PA Proof that the 7-carboxyglutamic acidcontaining bone protein is synthesized in calf bone. Comparative synthesis rate and effect of coumadin on synthesis. J Biol Chem. 1979; 254(2):437-441.
26. Nishimoto SK, Price PA The vitamin K-dependent bone protein is accumulated within cultured osteosarcoma cells in the presence of the vitamin K antagonist warfarin. J Biol Chem. 1985; 260(5):2832-2836.
27. Nishimoto SK. A colorimetric assay specific for 7-carboxyglutamic acid-containing proteins: its utility in protein purification procedures. Anal Biochem. 1990; 186(2):273-279.
28. Nishimoto SK, Araki N, Robinson F.D., Waite JH. Discovery of bone γ-carboxyglutamic acid protein in mineralized scales. The abundance and structure of Lepomis macrochirus bone 7-carboxyglutamic acid protein. J Biol Chem. 1992; 267(16):11600-11605.
29. Novak JF, Hayes JD, Nishimoto SK Plasmin-mediated proteolysis of osteocalcin. J Bone Miner Res. 1997; 12(7):1035-1042.
30. Sabek OM, Cowan P, Fraga D.W., Gaber AO. The effect of isolation methods and the use of different enzymes on islet yield and in vivo function. Cell Transplant. 2008; 17(7):785-792.
31. Fraga DW, Sabek O, Hathaway D.K., Gaber AO. A comparison of media supplement methods for the extended culture of human islet tissue. Transplantation. 1998; 65(8):1060-1066.
32. Buchwald P, Wang X, Khan A., et al. Quantitative assessment of islet cell products: estimating the accuracy of the existing protocol and accounting for islet size distribution. Cell Transplant. 2009; 18(10): 1223-1235.
33. Balamurugan AN, Naziruddin B, Lockridge A., et al. Islet product characteristics and factors related to successful human islet trans-plantation from the Collaborative Islet Transplant Registry (CITR) 1999-2010. Am J Transplant. 2014; 14(11):2595-2606.
34. Ichii H, Sakuma Y, Pileggi A., et al. Shipment of human islets for transplantation. Am J Transplant. 2007; 7(4):1010-1020.
35. Eckhard M, Brandhorst D, Winter D., et al. The role of current product release criteria for identification of human islet preparations suitable for clinical transplantation. Transplant Proc. 2004; 36(5):1528-1531.
36. Sabek OM, Fraga DW, Minoru O, McClaren J.L., Gaber AO. Assessment of human islet viability using various mouse models. Transplant Proc. 2005; 37(8):3415-3416.
37. Sweet IR, Gilbert M, Jensen R., et al. Glucose stimulation of cytochrome C reduction and oxygen consumption as assessment of human islet quality. Transplantation. 2005; 80(8):1003-1011.
38. Gaber AO, Fraga DW, Callicutt C.S., Gerling IC, Sabek OM, Kotb MY. Improved in vivo pancreatic islet function after prolonged in vitro islet culture. Transplantation. 2001; 72(11):1730-1736.
39. Ichii H, Inverardi L, Pileggi A., et al. A novel method for the assessment of cellular composition and β-cell viability in human islet preparations. Am J Transplant. 2005; 5(7):1635-1645.
40. Ashcroft FM, Harrison DE, Ashcroft SJ Glucose induces closure of single potassium channels in isolated rat pancreatic β-cells. Nature. 1984; 312(5993):446-448.
41. Bennett K, James C, Hussain K. Pancreatic β-cell KATP channels: hypoglycaemia and hyperglycaemia. Rev Endocr Metab Disord. 2010; 11(3):157-163.
42. Naggert JK, Fricker LD, Varlamov O, et al Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet. 1995; 10(2):135-142.
43. Portela-Gomes G.M., Grimelius L, Stridsberg M. Prohormone convertases 1/3,2, furin and protein 7B2 (secretogranin V) in endocrine cells of the human pancreas. Regul Pept. 2008; 146(1-3):117-124.
44. Schwetz V, Pieber T, Obermayer-Pietsch B. The endocrine role of the skeleton: background and clinical evidence. Eur J Endocrinol. 2012; 166(6):959-967.
45. Yatoh S, Dodge R, Akashi T., et al. Differentiation of affinity-purified human pancreatic duct cells to β-cells. Diabetes. 2007; 56(7): 1802-1809.
46. Talchai C, Xuan S, Lin H.V., Sussel L., Accili D. Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure. Cell. 2012; 150(6):1223-1234.
47. Thorel F, Népote V, Avril I., et al. Conversion of adult pancreatic α-cells to β-cells after extreme β-cell loss. Nature. 2010; 464(7292): 1149-1154.
48. Weir GC, Aguayo-Mazzucato C, Bonner-Weir S.β-Cell dedifferentiation in diabetes is important, but what is it? Islets. 2013; 5(5): 233-237.
49. Yeap BB, Alfonso H, Chubb S.A., et al. Higher serum undercarboxy-lated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older men. J Clin Endocrinol Metab. 2015; 100(1):63-71.
50. Kanazawa I, Yamaguchi T, Tada Y., Yamauchi M, Yano S, Sugimoto T. Serum osteocalcin level is positively associated with insulin sensitivity and secretion in patients with type 2 diabetes. Bone. 2011; 48(4):720-725.
51. Hoiriis Nielsen J., Nielsen V, Molsted Pedersen L, Deckert T. Effects of pregnancy hormones on pancreatic islets in organ culture. Acta Endocrinol (Copenh). 1986; 111(3):336-341.
52. Wei J, Hanna T, Suda N., Karsenty G, Ducy P. Osteocalcin promotes β-cell proliferation during development and adulthood through Gprc6a. Diabetes. 2014; 63(3):1021-1031.
53. Farber CR, Chitwood J, Lee S.N., et al. Overexpression of Scg5 increases enzymatic activity of PCSK2 and is inversely correlated with body weight in congenic mice. BMC Genet. 2008; 9:34.
54. Gloyn AL, Siddiqui J, Ellard S. Mutations in the genes encoding the pancreatic β-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat. 2006; 27(3):220-231.